The President of the Republic of Poland said that about the BioNanoPark that has been officially opened today at 10am in Lodz. The President of the Republic of Poland, Bronisław Komorowski accompanied by the Minister of Health, Minister of Regional Development, the President of Lodz and rectors of th...
Read more
The innovative bib-business is a main – apart form the IT – driving force of the modern economy. Therefore, every year since 2001 we organize BioForum – the event that meets the needs of the emerging Central European biotech companies and creates the optimal conditions for their development....
Read more
Mabion SA – polish biotech company – submitted to the Serbian Ministry of Health all the scientific and legal documentation required to register the clinical trials of MabionCD20 – a drug that is to be used in blood cancer and rheumatoid arthritis treatment. Serbia is the second of all 8 selected Eur...
Read more
Kaunas University of Technology is organizing a one-day conference to discuss the current status of innovation eco-system at this particular institution. The event will take place on the 30th of November 2012 in the historical aula of Kaunas University of Technology....
Read more
BIOCEV is a joint project of six institutes of the Academy of Sciences of the Czech Republic and two faculties of Charles University in Prague....
Read more
To celebrate 60 years since the pivotal moment in history when DNA was discovered as a three-dimensional double-helix structure- EuropaBio announces the launch of ‘European Biotech Week’. It will take place across Europe every year during the first week of October and will encourage all European citi...
Read more
The CONTIPRO company was created in 1990 by Vladimír Velebnýand Petr Pinkas. Its name is a composite of “connective tissue products”, which are widely used in the pharmaceutical and cosmetic industries. The companyhas been involved in R&D and biotechnological production of active ingredients for the ...
Read more
Wellington Partners - a Venture Capital firm that invests in promising life sciences start-up companies throughout Europe managed to gather 70 million € from leading international investors. The target group for the new fund includes companies that operate in innovative medical device sector, diagnos...
Read more
Hungarian Biotechnology Association (HBA) was established by the countries leading biotech companies with the aim of promoting the development of the Hungarian biotech sector and it’s representation at the international exhibitions and conferences....
Read more
Polish biotechnology company Euroimplant S.A. has launched a new service based on a method of isolation of ADSC - Adipose Derived Steam Cells, which was developed by the research team of the company and is performed basing on a certificate of the Polish Ministry of Health....
Read more
In an exciting twist, two companies have been announced as winners of EuropaBio’s Most Innovative Biotech SME Award 2012. Commission Vice President Tajani who presented the award, during the event hosted by Dr. Kay Swinburne MEP at the European Parliament on 19th September, named both Austrian healt...
Read more
We live and work in Central Europe. Our region is formed by countries recentlyliberated from a totalitarian communist regime. We have common cultural and historical roots and face similar social, political and economic problems. One of our common strategic goals is to quickly make up for the technol...
Read more
Euroimplant S. A. has recently gained a patent concerning their newest inventions – the “Bioreaktor”. The invention is adjusted to tissue engineering (e.g. 3D cell culture) and in vivo toxicology as well as many other biotechnological applications....
Read more
The Annual PHARM Connect Congress for Enlarged Europe is one of the largest pharmaceutical and biotechnology manufacturing events in Central and Eastern Europe and the CIS market in 2013.
The event is bringing together around 500 senior decision-makers from Europe’s leading pharmaceutical and biot...
Read more
The new projet of the co-partnership considering “Utilization of genomic diagnostics in development of personalized medicine” gets a sponsor - the Polish Agency of Enterprise Development (pol. Polska Agencja Rozwoju Przedsiębiorczości, PARP). The funding reaches nearly a million EUR (about 3 mio PLN)...
Read more
Mabion co. – Polish biotech company runing research on biosimilar pharmaceuticals– has signed an intent letter on cooperation with Turkish pharma company in terms of introduction of MabionCD20 medicine to the Turkish market. Annual income from sales of MabThera – the reference of MabionCD20 – in Turk...
Read more
SOLVO Biotechnology (SOLVO, www.solvo.com), has appointed two internationally renowned American scientists to top management positions in the company. The pioneer and market leader in the field of transporters recently opened a fully owned subsidiary in Boston, MA, and has started addingGLP services ...
Read more
Actavis has introduced a drug containing atorvastatin in 8 european markets where patent protection of Lipitor® /Zarator® from Pfizer has just expired. Lipitor®`s generic equivalent produced by Actavis will be from now available in Germany, Denmark, UK, France, Netherlands, France and Italy....
Read more
Ubichem Research Ltd announced further growth of its business by adding a new manufacturing site. The new member of the group, UBICHEM Pharma Manufacturing, will be producing starting materials, intermediates and other fine chemical products for pharma and non-pharma applications in industrial quanti...
Read more